Cellink LLC:1318379 [19-003127]
Ended Purchase Order Awarded
- Contract number
- 75N95019P00308
- Awardee
-
Cellink LLC UEI QCK1LDJ3A6K5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $96,978
Award facts
- Opportunity
-
- 3-D bioprinter capable of generating a 3D construct with pluripotent stem cells and their differentiated counterparts Solicitation · 75N95019Q00150 · Posted May 2, 2019
- Contract value 100% obligated
- $96,978.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 333244 Printing Machinery and Equipment Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 5 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
This is a $96,978.00 firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Cellink LLC, a foreign-owned for-profit biotech company. The contract was awarded under a small business set-aside and provides for the delivery of two 3D bioprinters capable of generating 3D constructs with pluripotent stem cells and their differentiated counterparts. The bioprinters are to include various advanced features such as layer and positioning resolution up to 1 micron, environmental controls, and the ability to use a variety of biocompatible bio-inks. The period of performance is from the award date of May 20, 2019 through the ultimate completion date of July 1, 2019. Cellink LLC has secured numerous other federal contracts from agencies like NIH, VA, EPA, FDA, USDA, DoD, and Commerce to provide bioconvergence technologies supporting biomedical research.
Quick answers
Who was awarded contract 75N95019P00308?
75N95019P00308 was awarded to Cellink LLC by National Institute on Drug Abuse (National Institutes of Health) on May 20, 2019.
How much is contract 75N95019P00308 worth?
The government has obligated $96,978 on 75N95019P00308.
Which agency awarded contract 75N95019P00308?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95019P00308, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95019P00308 competed?
The extent of competition for 75N95019P00308 was competed under sap. The government received 5 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award